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Introduction
• Colorectal cancer (CRC) is considered
preventable cancer if diagnosed in the early
stage.
• CRC is second leading cause of death from
cancer in US.
• Bone metastases (BM) is an uncommon
presentation in CRC and if it occurs, it involves
the axial skeletal more than extremities.
• Many case studies also report that survival after
BM is considerably poor than without BM.
• Cancer type and genetic mutations also play an
important role in such metastasis.

Case Report
• 62-year-old female with pertinent Past Medical
History of adenocarcinoma of colon with 5.4 cm
Cecal lesion s/p right hemicolectomy with 0/14
positive lymph nodes.
• She received Capecitabine post-operatively.
• Approximately one and a half year later, patient
developed progressive left knee pain.
• MRI knee showed left medial femoral condyle
mass with associated soft tissue and bone scan
showed increased uptake in the same area.
• Biopsy results showed adenocarcinoma
consistent with colon primary.

Case Report(Cont.)
• PET CT showed parotid gland and lung nodule
with a central mesentery node and a soft tissue
density in T9-T10 anterior vertebrae.
• She was referred for palliative Radiation and
chemotherapy- FOLFOX-Bevacizumab and
bisphosphonate.
Relevant genetic studies:
Adenocarcinoma type CRC - positive for CK-20 and
CDX-2.
K-RUS mutation in codon 12 and 13
No NRAS, BRAF, V600E or V600K mutation
CEA- Within Normal Limit

Imaging

Results
• CRC is considered as a curable cancer if
diagnosed in the early stage, but it can be deadly
if metastasizes to other organ system.
• Some studies show that prognosis dependents on
the site of metastasis. If metastases to liver or
lung present and if they are resectable, prognosis
is favorable.
• Nonetheless, bony metastasis is characterize as
poor prognosis.
• Vatandoust & coworker suggested that with signet
ring cell cancer, chances of getting BM is higher
than other types of CRC (up to 23.7%).
• In our case, patient had adenocarcinoma type
CRC and it is not commonly associated with BM.
• Our patient had BM involving appendicular
skeleton that is an uncommon presentation. To
add, patient had K-RUS mutation and that is also
not common mutation type associated with BM.

Conclusion
• We suggest that more molecular studies related
to K-RUS and other mutations, and their
association with BM need to be done in CRC. It
can also help deciding appropriate treatment plan
at the early stage.
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